How AI is changing the decision landscape for pharma commercial operations
Key takeaways
- AI is reshaping pharma commercial operations decision-making by giving field and business leaders faster ways to develop early perspectives.
- To better address these new ways of working, commercial operations leaders must embed AI into workflows to ensure trust and auditability, preserve analytical rigor and elevate teams toward strategic judgment.
- Purpose-built AI platforms for pharma can help turn commercial operations achieve these priorities and lead to faster, more governed and more defensible decisions.
Data-driven decisions and AI are not entirely new to commercial pharma teams. Field users have used it in their day-to-day execution of next-best actions, field coaching and home-office users to optimize their field planning and operations.
What has changed is the reach of AI and ease of access to all the users within an organization including sales and business leaders. Traditionally, business and sales leaders accessed information via standard reports with flexibility to drill down information as they need. However, with increasing access to AI, business leaders are beginning to use AI to develop insights into a range of business problems, through structured or exploratory analysis.
Commercial operations functions such as territory design, sales force sizing, placement and sales compensation have long sat with commercial operations because they require time, data access, domain knowledge and analytical skills. But AI quietly narrows the time, data and skill-set gap by allowing sales leaders to work with data through AI agents more comfortably than before. These new ways of working have given rise to a shift in where decisions begin, how quickly they form and what commercial operations teams are expected to contribute. Decisions that once waited for a formal request, a centralized analysis and a structured review cycle are now being shaped earlier by business users who can generate their own working viewpoints in minutes.
This shift raises the bar for commercial operations teams to bring stronger context, clearer logic and more defensible recommendations to decisions that are already moving. This shows up in two ways across day-to-day functions:
AI as a starting point: A franchise lead runs a quick AI-assisted model to plan the deployment of additional sales force headcount for a newly approved indication and brings it to commercial operations as a starting point. That's the head start and engagement commercial operations has always sought from field leadership.
AI as a sticking point: The field leader has already formed a view, the AI-generated number is sitting in their notes, and now they want to know why commercial operations' analysis says something different. That's a credibility conversation, and it's a position commercial operations team hasn’t historically had to defend.
Both conversations are already happening. The real question is not whether commercial operations will encounter them, but whether the function's own analysis, teams and systems are grounded in something structurally stronger than what the field now can access and analyze.
That is where a purpose-built AI platform for pharma becomes the foundation, not just another tool. Commercial operations needs AI that can work from connected data, reflect pharma-specific workflows and apply the governance, context and rigor required for decisions that affect field execution, customer engagement and commercial performance. With that foundation in place, leaders can move from reacting to AI-generated viewpoints in the field to shaping how organizational AI supports faster, stronger and more strategic decision-making.
Five organizational AI priorities for pharma commercial operations
Regional and field leaders don't always have access to the same integrated platform that headquarters uses, so there is potential for business users to default to generic AI tools. And while a generic AI assistant may answer a question, it does not automatically understand pharma workflows, commercial context or the logic behind recurring business decisions. Commercial teams need AI embedded into the way work happens—supported by domain logic, industry benchmarks and patterns from similar commercial challenges.
Close this gap by identifying workflows and activities that are currently handled through manual touch points. Automate and enable them via the platform and extend access to all users. This way all users are looking at the same information and are using the best-in-class platform with relevant pharma context to derive insights and strategies instead of independently using tools and agents at their disposal.
Together, these priorities point to a bigger question about how commercial operations should evolve as AI becomes a more active part of day-to-day decision-making.
What AI means for the future of pharma commercial operations
The trend of business leaders experimenting with AI is a healthy sign that shows they have more curiosity about the business, willingness to engage with data and energy directed at the same problems commercial operations exists to solve.
The real question is whether commercial operations leaders are building their end-to-end workflows on systems and platforms equipped to meet this shift—and to position the function as a more strategic partner to the business.
With ZAIDYN®, the life sciences intelligence platform, pharma commercial operations teams can meet these priorities through connecting data, workflows and AI-powered decision support in one purpose-built environment. By grounding AI in pharma-specific context, ZAIDYN helps teams make faster decisions without losing the trust, auditability and rigor commercial operations requires.
Related resources
See ZAIDYN in action
